We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Court Upholds Pfizer Patent For Norvasc

Law360 (January 18, 2006, 12:00 AM EST) -- Pfizer, deflecting challenges from several generic drug makers over the patents for its second best-selling drug Norvasc, has prevailed in one of the cases, with a judge blocking an attempt by Apotex to launch a generic version of the blood pressure treatment.

A judge in an Illinois District Court upheld Pfizer’s patent for the main ingredient in the drug, which is not set to expire until September 2007.

The blockbuster blood pressure drug is Pfizer’s second-biggest earner, bringing in $3.46 billion, or 9% of corporate sales,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.